Related Experiment Videos
Azlocillin and the immune response in intensive care
L B Santamaria1, A U Sinardi, T Mandolfino
1Pluridisciplinary Institute of Anesthesiology, Resuscitation and Intensive Care, University of Messina, Italy.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|December 1, 1987
Summary
This study investigated azlocillin
Area of Science:
- Immunology and Infectious Diseases
- Pharmacology and Therapeutics
Background:
- Patients in intensive care units (ICUs) with severe respiratory infections often have compromised immune systems.
- Antibiotic therapies are crucial but may potentially interfere with immune function in critically ill patients.
Purpose of the Study:
- To evaluate the impact of azlocillin, a semisynthetic penicillin, on immunological parameters in ICU patients with severe respiratory infections.
- To determine if azlocillin exhibits any immunodepressing activity in this vulnerable patient population.
Main Methods:
- Monitoring of immunological cellular and humoral parameters.
- Involved 12 patients in the Intensive Care Unit at the University Polyclinic of Messina.
- Patients received antibiotic therapy with azlocillin for severe respiratory infections.
Main Results:
- The study observed immunological cellular and humoral parameters in patients undergoing azlocillin treatment.
- The results indicated no significant adverse effects on the immune system.
Conclusions:
- Azlocillin treatment did not appear to suppress the immune system in critically ill patients with severe respiratory infections.
- The findings suggest that azlocillin can be safely used in this context without exacerbating immune deficits.